The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2025

Filed:

Dec. 02, 2019
Applicant:

Neurent Medical Limited, Oranmore, IE;

Inventors:

David Townley, Clare, IE;

Brian Shields, Galway, IE;

Assignee:

Neurent Medical Limited, Oranmore, IE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2005.12); A61B 34/10 (2015.12); A61B 34/20 (2015.12); A61N 1/05 (2005.12); A61N 1/40 (2005.12); G06T 7/00 (2016.12); A61B 17/00 (2005.12); A61B 18/00 (2005.12); A61B 18/02 (2005.12); A61B 18/12 (2005.12); A61B 18/18 (2005.12); A61B 18/20 (2005.12); A61B 90/00 (2015.12); A61B 90/94 (2015.12);
U.S. Cl.
CPC ...
A61B 18/1485 (2012.12); A61B 18/14 (2012.12); A61B 34/10 (2016.01); A61B 34/20 (2016.01); A61N 1/0546 (2012.12); A61N 1/403 (2012.12); G06T 7/0012 (2012.12); A61B 2017/00199 (2012.12); A61B 2017/00292 (2012.12); A61B 2017/00424 (2012.12); A61B 2017/00867 (2012.12); A61B 2018/0016 (2012.12); A61B 2018/00166 (2012.12); A61B 2018/00214 (2012.12); A61B 2018/00303 (2012.12); A61B 2018/00327 (2012.12); A61B 2018/00434 (2012.12); A61B 2018/00577 (2012.12); A61B 2018/00654 (2012.12); A61B 2018/00815 (2012.12); A61B 2018/00821 (2012.12); A61B 2018/00875 (2012.12); A61B 2018/00922 (2012.12); A61B 2018/00946 (2012.12); A61B 18/02 (2012.12); A61B 18/1206 (2012.12); A61B 2018/1253 (2012.12); A61B 2018/126 (2012.12); A61B 2018/1407 (2012.12); A61B 2018/144 (2012.12); A61B 2018/1467 (2012.12); A61B 2018/1475 (2012.12); A61B 2018/1823 (2012.12); A61B 18/20 (2012.12); A61B 2034/102 (2016.01); A61B 2090/3735 (2016.01); A61B 2090/3762 (2016.01); A61B 2090/378 (2016.01); A61B 90/94 (2016.01); A61B 2218/007 (2012.12);
Abstract

The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The system includes a device including a multi-segment end effector for delivering energy to one or more target sites within the nasal cavity of the patient. The multi-segment end effector includes a first segment and a separate second segment, wherein each of the first and second segments is transformable between a retracted configuration and an expanded deployed configuration, the first segment having a first geometry when in the deployed configuration to complement anatomy at a first location within the nasal cavity and a second segment having a second geometry when in the deployed configuration to complement anatomy at a second location within the nasal cavity.


Find Patent Forward Citations

Loading…